Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Manonelles

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Nefrologia|April 13, 2024
Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratioAnna Vidal-Alabró, Helena Colom, Pere Fontova, et al.
Kidney International Reports|July 11, 2018
Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant OutcomeMaria Meneghini, Edoardo Melilli, Jaume Martorell, et al.
Kidney International Reports|January 18, 2018
Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant RecipientsJosep M Cruzado, Ricardo Lauzurica, Julio Pascual, et al.
Clinical Transplantation|March 8, 2021
Adoption of a novel smart mobile-health application technology to track chronic immunosuppression adherence in solid organ transplantation: Results of a prospective, observational, multicentre, pilot studyEdoardo Melilli, Giuseppe Cestone, Ignacio Revuelta, et al.
Transplantation Reviews (Orlando, Fla.)|May 9, 2024
Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysisLaia Oliveras, Ana Coloma, Nuria Lloberas, et al.
Open Forum Infectious Diseases|June 20, 2019
Antibiotic Treatment Versus No Treatment for Asymptomatic Bacteriuria in Kidney Transplant Recipients: A Multicenter Randomized TrialNúria Sabé, Isabel Oriol, Edoardo Melilli, et al.
Kidney International|March 10, 2017
Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipientsElena Crespo, Paolo Cravedi, Jaume Martorell, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 12, 2024
Benefits of Living Over Deceased Donor Kidney Transplantation in Elderly Recipients. A Propensity Score Matched Analysis of a Large European Registry CohortNéstor Toapanta, Jordi Comas, Ignacio Revuelta, et al.
Transplantation|April 14, 2017
Effector Antitumor and Regulatory T Cell Responses Influence the Development of Nonmelanoma Skin Cancer in Kidney Transplant PatientsElena Crespo, Loreto Fernandez, Marc Lúcia, et al.
Frontiers in Pharmacology|October 4, 2024
Guiding the starting dose of the once-daily formulation of tacrolimus in "<i>de novo"</i> adult renal transplant patients: a population approachBeatriz Fernández-Alarcón, Oscar Nolberger, Anna Vidal-Alabró, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Nefrologia|April 13, 2024
Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratioAnna Vidal-Alabró, Helena Colom, Pere Fontova, et al.
Kidney International Reports|July 11, 2018
Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant OutcomeMaria Meneghini, Edoardo Melilli, Jaume Martorell, et al.
Kidney International Reports|January 18, 2018
Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant RecipientsJosep M Cruzado, Ricardo Lauzurica, Julio Pascual, et al.
Clinical Transplantation|March 8, 2021
Adoption of a novel smart mobile-health application technology to track chronic immunosuppression adherence in solid organ transplantation: Results of a prospective, observational, multicentre, pilot studyEdoardo Melilli, Giuseppe Cestone, Ignacio Revuelta, et al.
Transplantation Reviews (Orlando, Fla.)|May 9, 2024
Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysisLaia Oliveras, Ana Coloma, Nuria Lloberas, et al.
Open Forum Infectious Diseases|June 20, 2019
Antibiotic Treatment Versus No Treatment for Asymptomatic Bacteriuria in Kidney Transplant Recipients: A Multicenter Randomized TrialNúria Sabé, Isabel Oriol, Edoardo Melilli, et al.
Kidney International|March 10, 2017
Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipientsElena Crespo, Paolo Cravedi, Jaume Martorell, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 12, 2024
Benefits of Living Over Deceased Donor Kidney Transplantation in Elderly Recipients. A Propensity Score Matched Analysis of a Large European Registry CohortNéstor Toapanta, Jordi Comas, Ignacio Revuelta, et al.
Transplantation|April 14, 2017
Effector Antitumor and Regulatory T Cell Responses Influence the Development of Nonmelanoma Skin Cancer in Kidney Transplant PatientsElena Crespo, Loreto Fernandez, Marc Lúcia, et al.
Frontiers in Pharmacology|October 4, 2024
Guiding the starting dose of the once-daily formulation of tacrolimus in "<i>de novo"</i> adult renal transplant patients: a population approachBeatriz Fernández-Alarcón, Oscar Nolberger, Anna Vidal-Alabró, et al.
Pageof 6